ArticleCureus2026
Study of Vitamin D and Serum Calcium Levels in Type 2 Diabetes Mellitus.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionType 2 diabetes mellitus (T2DM) is a growing global health concern. Emerging evidence suggests that vitamin D and calcium play an important role in glucose metabolism and insulin function. The present study aimed to compare serum vitamin D and calcium levels between patients with T2DM and healthy controls and evaluate their association with glycaemic control (HbA1c). MATERIALS AND
methodsThis hospital-based case-control study included 136 participants, comprising 68 patients with T2DM and 68 healthy controls. Serum vitamin D and calcium levels were estimated, along with fasting blood sugar (FBS), postprandial blood sugar (PPBS), and glycated haemoglobin (HbA1c). Vitamin D and calcium status were categorized using standard cut-offs. Statistical analysis was performed using an independent t-test, chi-square test, and Pearson correlation.
resultsGlycaemic parameters were significantly higher in diabetic patients, including FBS (149.7 ± 51.0 vs. 87.2 ± 14.2 mg/dL), PPBS (223.5 ± 77.3 vs. 123.5 ± 17.6 mg/dL), and HbA1c (9.4 ± 2.1% vs. 5.1 ± 0.4%) (p = 0.001). Serum calcium (8.3 ± 0.7 vs. 9.0 ± 0.6 mg/dL) and vitamin D (20.23 ± 9.07 vs. 25.21 ± 8.23 ng/mL) were significantly lower in diabetics (p = 0.001). Vitamin D deficiency was more prevalent in diabetic patients (34 (50.0%) vs. 20 (29.4%); p = 0.038), and hypocalcaemia was also significantly higher (38 (55.9%) vs. 18 (26.5%); p = 0.001). Serum vitamin D (r = -0.412, p = 0.001) and calcium (r = -0.356, p = 0.002) showed significant negative correlation with HbA1c.
conclusionPatients with T2DM have significantly lower serum vitamin D and calcium levels, which are associated with poor glycaemic control. Assessment of vitamin D and calcium status may help identify micronutrient abnormalities in patients with T2DM; however, interventional studies are required to determine clinical benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.